Guardant Health’s Shield blood test has already been used by hundreds of thousands of people since its 2025 launch, with…
Browsing: Clinical Updates
This multicentre, three-armed non-inferiority randomised controlled trial (RCT) included patients with IBS (Rome IV, 16–75 years). Patients were randomised to…
A real-world study of 219 adults with suspected IBS found that patients who underwent IBS-Smart and/or Trio-Smart testing had lower…
A 21-year population-level analysis from Spain’s Basque Country found that an organized fecal immunochemical test (FIT) screening program was associated…
Researchers at Yonsei University have identified a microbial signature in saliva that could help distinguish people with gastrointestinal cancers, including…
A UK registry study comparing the new Rome V IBS diagnostic criteria with Rome III and Rome IV found that…
A real-world study published in Frontiers in Gastroenterology examined whether IBS-Smart and Trio-Smart testing was associated with differences in healthcare…
A new meta-analysis of 10 studies involving 4,374 patients examined why colon capsule endoscopy (CCE) remains limited by incomplete exams…
A meta-analysis of nearly 6,800 gut microbiome sequencing profiles has identified a consistent microbial signature associated with colorectal cancer, including…
In the first installment of an Expert Picks series highlighting research from DDW 2026, gastroenterology leaders Rajesh N. Keswani, MD,…